Aardvark Therapeutics, Inc. AARD
5.06
(0.49)
(8.83%)
as of 25 Sep
- Market cap
- $121.5M
- P/E
- 0.0×
Follow AARD
Insider Buys
alert about insiders buying in the last 12 month
| Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|
Current Ratio |
27.72 | 7.50 | 15.05 | 10.61 |
Net Debt/EBITDA |
1.43 | 1.35 | 3.22 | 1.72 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
— | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.78 | 0.81 | 0.88 | 0.94 |
Capex/Depreciation |
0.00 | — | 1.36 | 0.07 |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 |
| 0.00% | 22.98% | 46.03% | (221.55%) | |
| 0.00% | (52.82%) | (46.77%) | (59.16%) | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(85.33%) | (80.21%) | (29.75%) | (56.83%) |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% |
Free Cash Flow per Share |
(2.71) | (1.47) | (4.55) | (2.77) |
Cash per Share |
4.14 | 2.52 | 18.43 | 5.61 |
Shareholders Equity per Share |
4.11 | 2.30 | 18.04 | 5.43 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
4.11 | 2.30 | 18.04 | 5.43 |
Free Cash Flow |
(10.54) | (5.82) | (18.20) | (54.27) |
Working Capital |
15.90 | 8.99 | 69.21 | 101.34 |
Capital Expenditures |
— | — | (0.11) | (0.09) |
Net Current Asset Value |
15.72 | 8.93 | 68.74 | 101.34 |
| Other line items | ||||
Quick Ratio |
27.07 | 7.23 | 14.95 | 10.43 |
Depreciation/Fixed assets |
0.00 | — | 0.00 | 0.00 |
Cash ROIC |
(32.86%) | (30.51%) | (12.41%) | (25.00%) |
Accounts Payable Turnover |
— | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(2.71) | (1.47) | (4.53) | (2.76) |
Capex per Share |
0.00 | 0.00 | (0.03) | 0.00 |
Average Payables |
— | 0.65 | 1.67 | 2.19 |
Average Assets |
— | 13.65 | 44.02 | 97.34 |
Average Common Equity |
— | (31.36) | (44.72) | 26.00 |
Capex to Sales |
— | — | 0.00 | 0.00 |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates